Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

We haven't written up this one. CNBC World has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at cnbc.com →

More in Health & Medicine

More from Wednesday 19 August →